多瑞医药拟出售不超104.45万股已回购股份

Core Viewpoint - The company, Duori Pharmaceutical (301075.SZ), has approved a share repurchase plan to sell back shares through centralized bidding, with a total of up to 1.0445 million shares, representing 1.31% of the company's total share capital [1] Group 1 - The board of directors has passed a resolution regarding the share repurchase plan [1] - The repurchased shares will be sold within a period starting 15 trading days after the announcement and lasting for 6 months, specifically from January 14, 2026, to July 13, 2026 [1] - The selling price of the repurchased shares will be determined based on the secondary market price [1]